Has Ali Malek, MD received payments from drug or device companies?

Yes. Drug and device makers reported $116,585 in general payments to Ali Malek, MD across 186 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ali Malek, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ali Malek, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ali Malek, MD

Neurology · West Palm Beach, FLNPI 1255354478

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $74,055 of the $116,585 with a category attached, or 63.5%. Stryker accounts for 72.9% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2020 at $54,442 and has fallen 99.3% since, to $375 in 2025. Among neurology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$116,585in general payments, 2019–2025

Across 186 payments — averaging $626.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$85K
Microvention, Inc.$17K
Rapid Medical Ltd$11K
Penumbra, Inc.$637
Qapel Medical Inc$313
Medtronic$265
plus $2K from 20 others

$188,002in research payments, 2019–2025

Across 77 payments — averaging $2441.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medtronic$109K
Stryker$35K
Janssen Research & Development, LLC$24K
AstraZeneca$10K
Bayer$6K
Boehringer Ingelheim$3K
plus $2K from 1 others

What the payments were for

Consulting fees$74,05564%
Speaking & faculty fees$15,90014%
Travel & lodging$21,66019%
Food & beverage$4,9504%
Education$200%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	93	$85,048
Microvention, Inc.	26	$17,054
Rapid Medical Ltd	2	$11,129
Penumbra, Inc.	13	$637
Qapel Medical Inc	3	$313
Medtronic	13	$265
Novo Nordisk	2	$237
Johnson & Johnson	5	$219
SK Life Science, Inc.	2	$218
Abbott	2	$164
Imperative Care, Inc	4	$160
Boston Scientific	1	$140
AbbVie(2 entities)	2	$126
Eisai Inc.	1	$121
Jazz Pharmaceuticals Inc.	1	$109
Neurelis, Inc.	1	$100
Biohaven Pharmaceuticals, Inc.	1	$84
Edwards Lifesciences	2	$81
UCB, Inc.	2	$77
Irras USA, Inc.	1	$75
Balt USA, LLC	2	$63
Forte Bio-pharma LLC	2	$48
CSL Behring	2	$42
Route 92 Medical, Inc.	1	$40
Cardiva Medical, Inc.	1	$21
Chiesi USA, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$116,585 in reported general payments places this provider in the 95th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024

$27,780

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
BrilintaTicagrelor	11	$6,625
Atorvastatin Calcium	20	$102

Paid to pharmacies, not to this prescriber.

Other neurology in West Palm Beach

Nisha ChhabriaWest Palm Beach$182K
Arnaldo da SilvaWest Palm Beach$138K
Stuart IsaacsonBoca Raton$3.9M
Selim BenbadisTampa$2.1M
Derrick RobertsonTampa$1.8M
Robert HauserTampa$1.6M
David RoseTampa$1.4M
Matthew BakerNaples$1.4M
Donald NegroskiSarasota$1.4M
Mark CascioneTampa$1.2M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →